A team at the Oklahoma Heart Institute is helping patients across the globe with a groundbreaking device that could change how doctors treat mitral valve disease. Developed by Edwards Lifesciences and ...

One-year outcomes in the ENCIRCLE trial’s main cohort (299 patients unsuitable for other treatment options) achieved low rates for death and low heart failure hospitalization for patients treated with ...

The University of Akron's BETA Lab received a grant from the American Heart Association to help develop new, less invasive heart valve implants.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...